0001375852-16-000009.txt : 20160913
0001375852-16-000009.hdr.sgml : 20160913
20160913192216
ACCESSION NUMBER: 0001375852-16-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160913
FILED AS OF DATE: 20160913
DATE AS OF CHANGE: 20160913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Scott E
CENTRAL INDEX KEY: 0001375852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 161883872
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-09-13
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001375852
Lamb Scott E
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Financial Officer,
Common Stock
2016-09-13
4
X
0
324.0
43.62
A
4705
D
Common Stock
2016-09-13
4
S
0
324.0
122.0093
D
4381
D
Common Stock
2016-09-13
4
X
0
1150.0
43.12
A
5531
D
Common Stock
2016-09-13
4
S
0
450.0
120.8233
D
5081
D
Common Stock
2016-09-13
4
S
0
700.0
121.9329
D
4381
D
Non-Qualified Stock Option (right to buy)
43.12
2016-09-13
4
X
0
1150.0
43.12
D
2021-02-02
Common Stock
1150
0
D
Non-Qualified Stock Option (right to buy)
43.62
2016-09-13
4
X
0
324.0
43.62
D
2021-07-20
Common Stock
324
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.75 to $122.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.80 to $120.83, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.91 to $121.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
Transaction is the exercise of a derivative security; see Column 2.
By: Paula Darbyshire For: Scott E. Lamb
2016-09-13